Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells

Folic acid conjugated poly(amidoamine) dendrimer as a smart nanocarriers for tracing, imaging, and treating cancers over-expressing folate receptors

(2022) Mahak Fatima et al.   EUROPEAN POLYMER JOURNAL

Co-administration of tariquidar using functionalized nanostructured lipid carriers overcomes resistance to docetaxel in multidrug resistant MCF7/ADR cells

(2022) Chang Hyun Kim et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells

(2022) Maria João Ramalho et al.   LIFE SCIENCES

Synergistic co-administration of docetaxel and curcumin to chemoresistant cancer cells using PEGylated and RIPL peptide-conjugated nanostructured lipid carriers

(2022) Chang Hyun Kim et al.   Cancer Nanotechnology

Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview

(2021) S. Aishah A. Razak et al.   Cancers

Ligand decorated biodegradable nanomedicine in the treatment of cancer

(2021) Ejaj Ahmad et al.   PHARMACOLOGICAL RESEARCH

Tumor‐homing peptide and its utility for advanced cancer medicine

(2021) Eisaku Kondo et al.   CANCER SCIENCE

Synergistic potential of dual andrographolide and melatonin targeting of metastatic colon cancer cells: Using the Chou-Talalay combination index method

(2021) Vivekjyoti Banerjee et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Advancement in design of nanostructured lipid carriers for cancer targeting and theranostic application

(2021) Md. Rizwanullah et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review

(2020) Mohamed Haider et al.   Pharmaceutics

Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells

(2020) Chang Hyun Kim et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Mechanisms of docetaxel resistance in prostate cancer: The key role played by miRNAs

(2020) Milena Rizzo   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Receptor-based targeting of engineered nanocarrier against solid tumors: Recent progress and challenges ahead

(2020) Md. Habban Akhter et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells

(2020) Yuanwei Pan et al.   JOURNAL OF CONTROLLED RELEASE

Lipids and polymers in pharmaceutical technology: Lifelong companions

(2019) Juergen Siepmann et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Nanostructured lipid carriers (NLC) system: A novel drug targeting carrier

(2019) Vedanti R. Salvi et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Co-delivery of DOX and PDTC by pH-sensitive nanoparticles to overcome multidrug resistance in breast cancer

(2019) Xu Cheng et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5-Demethylnobiletin

(2019) Shenghu Guo et al.   BIOMEDICINE & PHARMACOTHERAPY

Construction and in vitro and in vivo evaluation of folic acid-modified nanostructured lipid carriers loaded with paclitaxel and chlorin e6

(2019) Qibo Zhang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Achillin Increases Chemosensitivity to Paclitaxel, Overcoming Resistance and Enhancing Apoptosis in Human Hepatocellular Carcinoma Cell Line Resistant to Paclitaxel (Hep3B/PTX)

(2019) Sanchez-Carranza et al.   Pharmaceutics

Predicting drug release kinetics from nanocarriers inside dialysis bags

(2019) Minzhi Yu et al.   JOURNAL OF CONTROLLED RELEASE

Liposome-based co-delivery of 7-O-geranyl-quercetin and IGF-1R siRNA for the synergistic treatment of non-small cell lung cancer

(2019) Meilin Jiang et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

RIPL peptide-conjugated nanostructured lipid carriers for enhanced intracellular drug delivery to hepsin-expressing cancer cells

(2018) Sang Gon Lee et al.   International Journal of Nanomedicine

Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers

(2018) Dereje Kebebe et al.   International Journal of Nanomedicine

Self-assembly of peptide-based nanostructures: Synthesis and biological activity

(2018) Léna Guyon et al.   Nano Research

Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles

(2018) Dazhong Chen et al.   International Journal of Nanomedicine

Sterically Stabilized RIPL Peptide-Conjugated Nanostructured Lipid Carriers: Characterization, Cellular Uptake, Cytotoxicity, and Biodistribution

(2018) Chang Kim et al.   Pharmaceutics

Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer

(2018) Shaheen Mahira et al.   BIOMEDICINE & PHARMACOTHERAPY

Surface-Modification of RIPL Peptide-Conjugated Liposomes to Achieve Steric Stabilization and pH Sensitivity

(2017) Yie Hyuk Kwon et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers

(2017) Manu S. Singh et al.   PHARMACOLOGICAL RESEARCH

Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer

(2017) Ravi Doddapaneni et al.   Scientific Reports

Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives

(2016) Rui Xue Zhang et al.   JOURNAL OF CONTROLLED RELEASE

The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles

(2016) Wanting Zou et al.   JOURNAL OF DRUG TARGETING

pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(d,l-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor

(2015) Yong Zhao et al.   Acta Biomaterialia

Taxane anticancer agents: a patent perspective

(2015) Iwao Ojima et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Design, synthesis and in vivo antitumor efficacy of novel eight-arm-polyethylene glycol–pterostilbene prodrugs

(2015) Ke-feng Liu et al.   RSC Advances

Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation

(2014) Tip W. Loo et al.   BIOCHEMICAL PHARMACOLOGY

Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy

(2014) Ankit Saneja et al.   CURRENT CANCER DRUG TARGETS

Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity

(2014) Jie Tang et al.   DRUG DELIVERY

PEGylated nanostructured lipid carriers (PEG–NLC) as a novel drug delivery system for biochanin A

(2014) Lei Wang et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes for enhanced intracellular drug delivery to hepsin-expressing cancer cells

(2014) Min Hyung Kang et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives

(2013) Ziyad Binkhathlan et al.   CURRENT CANCER DRUG TARGETS

Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies

(2012) S. Murray et al.   CANCER TREATMENT REVIEWS

Influence of precursor solvent properties on matrix crystallinity and drug release rates from nanoparticle aerosol lipid matrices

(2012) Amol Ashok Pawar et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations

(2012) Martti Kaasalainen et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes

(2012) Rita Nieto Montesinos et al.   JOURNAL OF CONTROLLED RELEASE

Physicochemical Characteristics of Nanoparticles Affect Circulation, Biodistribution, Cellular Internalization, and Trafficking

(2012) Xiaopin Duan et al.   Small

P-glycoprotein Inhibition: The Past, the Present and the Future

(2011) Richard A.J. Darby et al.   CURRENT DRUG METABOLISM

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

(2011) Twan Lammers et al.   JOURNAL OF CONTROLLED RELEASE

The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect

(2010) Jun Fang et al.   ADVANCED DRUG DELIVERY REVIEWS

Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance

(2009) Yogesh Patil et al.   JOURNAL OF CONTROLLED RELEASE

PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer

(2008) Xinxin Zhang et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY